P249 The prognostic role of 18F-fluorodeoxyglucose PET/CT in operable invasive breast carcinoma

The Breast ◽  
2015 ◽  
Vol 24 ◽  
pp. S111
Author(s):  
S.O. Hwang ◽  
J.K. Kang ◽  
J.O. Baek ◽  
J. Lee ◽  
W.W. Kim ◽  
...  
2020 ◽  
Vol 31 ◽  
pp. S326
Author(s):  
C.C. Tajima ◽  
A.G.V. Bitencourt ◽  
E.F. Marques ◽  
E.P.L. Nóbrega ◽  
R.A. De Mello

2011 ◽  
Vol 113 (2) ◽  
pp. 156-161 ◽  
Author(s):  
Winnie Wing-Chuen Lam ◽  
David Chee-Eng Ng ◽  
Wai Yin Wong ◽  
Seng Chuan Ong ◽  
Sidney Wing-Kwong Yu ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Natale Quartuccio ◽  
Ahmed Salem ◽  
Riccardo Laudicella ◽  
Alessandro Spataro ◽  
Agostino Chiaravalloti ◽  
...  

2001 ◽  
Vol 8 (1) ◽  
pp. S86-S86
Author(s):  
P ZANCO ◽  
A DESIDERI ◽  
C CERNETTI ◽  
S MODARRESL ◽  
E MILAN ◽  
...  

2019 ◽  
Vol 140 ◽  
pp. 54-61 ◽  
Author(s):  
Jon Magne Moan ◽  
Cecilie Delphin Amdal ◽  
Eirik Malinen ◽  
Jørund Graadal Svestad ◽  
Trond Velde Bogsrud ◽  
...  

Endocrines ◽  
2021 ◽  
Vol 2 (1) ◽  
pp. 28-36
Author(s):  
Ludovica Magi ◽  
Maria Rinzivillo ◽  
Francesco Panzuto

Owing to the rarity and the biological and clinical heterogeneity of gastroenteropancreatic neuroendocrine neoplasia (GEP NEN), the management of these patients may be challenging for physicians. This review highlights the specific features of GEP NEN with particular attention on the role of Ki67 heterogeneity, the potential prognostic role of novel radiological techniques, and the clinical usefulness of functional imaging, including 68Ga-DOTA-SST PET/CT and 18F-FDG PET/CT. Understanding these specific features may help to plan proper and tailored follow-up programs and therapeutic approaches.


Sign in / Sign up

Export Citation Format

Share Document